Open AccessLong-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial: Erratum
Publication year - 2018
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000013948
Subject(s) - medicine , immunogenicity , randomized controlled trial , tuberculosis , human immunodeficiency virus (hiv) , virology , immunology , pathology , immune system